Clinical Laserthermia Systems Americas

Clinical Laserthermia Systems Americas is the U.S. subsidiary of Clinical Laserthermia Systems AB and commercializes the TRANBERG Thermal Therapy System for minimally invasive focal laser ablation. The company focuses primarily on office- and clinic-based urology applications, especially image-guided focal treatment of localized prostate tumors using MRI/ultrasound fusion workflows. In the U.S., it provides sales, commercial development, operations, and clinical support for the TRANBERG system and related disposable accessories. CLS Americas has also supported clinical studies and research collaborations evaluating focal laser ablation in prostate cancer, including work with Urological Research Network, Focalyx, and the NIH Clinical Center. The broader CLS group also has activities in neurosurgery, but CLS Americas appears primarily oriented toward the U.S. urology market.